BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 24413735)

  • 1. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.
    Papaemmanuil E; Rapado I; Li Y; Potter NE; Wedge DC; Tubio J; Alexandrov LB; Van Loo P; Cooke SL; Marshall J; Martincorena I; Hinton J; Gundem G; van Delft FW; Nik-Zainal S; Jones DR; Ramakrishna M; Titley I; Stebbings L; Leroy C; Menzies A; Gamble J; Robinson B; Mudie L; Raine K; O'Meara S; Teague JW; Butler AP; Cazzaniga G; Biondi A; Zuna J; Kempski H; Muschen M; Ford AM; Stratton MR; Greaves M; Campbell PJ
    Nat Genet; 2014 Feb; 46(2):116-25. PubMed ID: 24413735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A RAG driver on the road to pediatric ALL.
    Kuiper RP; Waanders E
    Nat Genet; 2014 Feb; 46(2):96-8. PubMed ID: 24473322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
    Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
    Mendes RD; Sarmento LM; Canté-Barrett K; Zuurbier L; Buijs-Gladdines JG; Póvoa V; Smits WK; Abecasis M; Yunes JA; Sonneveld E; Horstmann MA; Pieters R; Barata JT; Meijerink JP
    Blood; 2014 Jul; 124(4):567-78. PubMed ID: 24904117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).
    Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.
    Lilljebjörn H; Henningsson R; Hyrenius-Wittsten A; Olsson L; Orsmark-Pietras C; von Palffy S; Askmyr M; Rissler M; Schrappe M; Cario G; Castor A; Pronk CJ; Behrendtz M; Mitelman F; Johansson B; Paulsson K; Andersson AK; Fontes M; Fioretos T
    Nat Commun; 2016 Jun; 7():11790. PubMed ID: 27265895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETV6-RUNX1-positive ALL may be driven by aberrant RAG activity.
    Cancer Discov; 2014 Mar; 4(3):OF15. PubMed ID: 24596209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV6/RUNX1 rearrangement identified by RT-PCR without evidence on FISH.
    Hahm C; Han SH; Mun YC; Seong CM; Chung WS; Huh J
    Acta Haematol; 2014; 132(1):122-4. PubMed ID: 24557455
    [No Abstract]   [Full Text] [Related]  

  • 10. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
    Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/-) leukemia.
    van der Weyden L; Giotopoulos G; Wong K; Rust AG; Robles-Espinoza CD; Osaki H; Huntly BJ; Adams DJ
    BMC Cancer; 2015 Aug; 15():585. PubMed ID: 26269126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
    Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
    Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection Exposure Promotes
    Rodríguez-Hernández G; Hauer J; Martín-Lorenzo A; Schäfer D; Bartenhagen C; García-Ramírez I; Auer F; González-Herrero I; Ruiz-Roca L; Gombert M; Okpanyi V; Fischer U; Chen C; Dugas M; Bhatia S; Linka RM; Garcia-Suquia M; Rascón-Trincado MV; Garcia-Sanchez A; Blanco O; García-Cenador MB; García-Criado FJ; Cobaleda C; Alonso-López D; De Las Rivas J; Müschen M; Vicente-Dueñas C; Sánchez-García I; Borkhardt A
    Cancer Res; 2017 Aug; 77(16):4365-4377. PubMed ID: 28630052
    [No Abstract]   [Full Text] [Related]  

  • 14. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Bokemeyer A; Eckert C; Meyr F; Koerner G; von Stackelberg A; Ullmann R; Türkmen S; Henze G; Seeger K
    Haematologica; 2014 Apr; 99(4):706-14. PubMed ID: 24241490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.
    Meissner B; Bartram T; Eckert C; Trka J; Panzer-Grümayer R; Hermanova I; Ellinghaus E; Franke A; Möricke A; Schrauder A; Teigler-Schlegel A; Dörge P; von Stackelberg A; Basso G; Bartram CR; Kirschner-Schwabe R; Bornhäuser B; Bourquin JP; Cazzaniga G; Hauer J; Attarbaschi A; Izraeli S; Zaliova M; Cario G; Zimmermann M; Avigad S; Sokalska-Duhme M; Metzler M; Schrappe M; Koehler R; Te Kronnie G; Stanulla M
    Hum Mol Genet; 2014 Feb; 23(3):590-601. PubMed ID: 24045615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fishing for ETV6/RUNX1 fusion and MLL gene rearrangements and their additional abnormalities in childhood acute lymphoblastic leukemia patients of Kashmir.
    Mohiuddin Malla T; Amin Shah Z; Hussain Bhat A; Ahmad Malik M; Anjum Baba R; Rasool R; Rasool J; Ashaq S; Haq F
    Gene; 2023 Mar; 856():147128. PubMed ID: 36565795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
    Mehtonen J; Teppo S; Lahnalampi M; Kokko A; Kaukonen R; Oksa L; Bouvy-Liivrand M; Malyukova A; Mäkinen A; Laukkanen S; Mäkinen PI; Rounioja S; Ruusuvuori P; Sangfelt O; Lund R; Lönnberg T; Lohi O; Heinäniemi M
    Genome Med; 2020 Nov; 12(1):99. PubMed ID: 33218352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.
    Sun C; Chang L; Zhu X
    Oncotarget; 2017 May; 8(21):35445-35459. PubMed ID: 28418909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
    Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
    Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis.
    Jakobczyk H; Jiang Y; Debaize L; Soubise B; Avner S; Sérandour AA; Rouger-Gaudichon J; Rio AG; Carroll JS; Raslova H; Gilot D; Liu Z; Demengeot J; Salbert G; Douet-Guilbert N; Corcos L; Galibert MD; Gandemer V; Troadec MB
    Leukemia; 2022 Feb; 36(2):549-554. PubMed ID: 34535762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.